Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.21
-0.17 (-5.03%)
At close: Sep 04, 2025, 11:12 AM
-5.03% (1D)
| Bid | 3.2 |
| Market Cap | 237.99M |
| Revenue (ttm) | 576K |
| Net Income (ttm) | -113.64M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -2.34 |
| Forward PE | -2.53 |
| Analyst | Buy |
| Ask | 3.21 |
| Volume | 161,471 |
| Avg. Volume (20D) | 977,733 |
| Open | 3.34 |
| Previous Close | 3.38 |
| Day's Range | 3.20 - 3.34 |
| 52-Week Range | 1.60 - 16.31 |
| Beta | 1.18 |
About CATX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CATX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CATX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Perspective Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+29.29%
Perspective Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
9 months ago
-51.38%
Perspective Therapeutics shares are trading lower. The company announced initial results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET.
